Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
This 3 day meeting of the ESC Working Group on Myocardial and Pericardial Diseases aims to communicate progress in basic science and practical management of myocardial and pericardial diseases to a broad audience with an interest in the conditions including physicians, specialist nurses, clinical researchers, pathologists, geneticists, basic scientist and young investigators.
The first day is dedicated to educational workshops with “How-to Sessions” and illustrative case study presentations. There will be a focus on genetics, imaging modalities including MRI, echocardiography and CT-scan, in addition to diagnosis and management of myocardial and pericardial diseases. There will also be sessions discussing the results of basic scientific research and the potential impact on clinical management and development of novel treatment modalities by use of gene therapy.
The remaining two days will have a focus on specific topics including genetics in hereditary cardiac conditions, diagnosis and treatment of myocarditis and pericarditis, algorithms for implantable devices for management of arrhythmia and resynchronization therapy, novel algorithms for medical heart failure therapy, mechanical support of advanced heart failure, palliation, rare myocardial conditions including Anderson-Fabry disease and amyloidosis, sports-medicine and prevention of sudden cardiac death.
Accepted abstracts which will be presented as posters and there will be an award for the three best presentations chosen by the scientific committee.
The majority of speakers will be internationally recognised experts in the field of myocardial and pericardial diseases.
Access the event website
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
Nyborg Strand Hotel
DK-5800 Nyborg, DK
© 2017 European Society of Cardiology. All rights reserved